# About

HiFiBiO Therapeutics is a clinical-stage biotech driving a pipeline of transformative immunotherapies.

## Leadership

### Deepak Rao, MD, PhD  
**Position**: Associate Professor of Medicine and Associate Physician, Harvard Medical School, and Co-Director, Center for Cellular Profiling, Brigham and Women’s Hospital  
  
[More about Deepak Rao](https://raolab.bwh.harvard.edu/team/)

### Leslie Kean, MD, PhD  
**Position**: Director of the Stem Cell Transplantation Program and Physician at Dana-Farber/Boston Children’s Cancer Center and Blood Disorders Center  
  
[More about Leslie Kean](http://www.danafarberbostonchildrens.org/finddoctor/details.aspx?ID=50459)

### Marco Londei, MD  
**Position**: Biotech Executive, Company Founder, Board Member, Physician Scientist, Drug Developer  
  
[More about Marco Londei](https://www.linkedin.com/in/marco-londei-8537379/)

### Michael Croft, PhD  
**Position**: Director of Academic Affairs, Professor for the Center of Autoimmunity and Inflammation at La Jolla Institute for Immunology  
  
[More about Michael Croft](https://www.lji.org/faculty-staff/michael-croft/)

### Peter Ho, MD, PhD  
**Position**: Former CMO at Boston Pharmaceuticals, Former CMO at Epizyme, Former President and Co-Founder at BeiGene, Former VP of Oncology Development at J&J  
  
[More about Peter Ho](https://www.linkedin.com/in/peter-ho-43460337/)

### Peter Taylor, MA, PhD, FRCP, FRCPE  
**Position**: Emeritus Professor of Musculoskeletal Sciences, University of Oxford  
  
[More about Peter Taylor](https://www.ndorms.ox.ac.uk/team/peter-taylor)

### Sebastian Amigorena, PhD  
**Position**: Director of the Cancer and Immunity Team, Head of the Center for Cancer Immunotherapy (Institut Curie, INSERM U932)  
  
[More about Sebastian Amigorena](https://institut-curie.org/person/sebastian-amigorena)